WHO warns against COVID-19 plasma therapy as US issues emergency authorization

On August 24, World Health Organization said using plasma from recovered patients to treat COVID-19 is still considered an “experimental”. WHO also said its work remains “low quality”. This came after United States issued emergency permission for such rapies. Convalescent plasma rapy has emerged as latest political flashpoint in race to find a cure against coronavirus.

Re: Duygu Elma, Woman Who Gave Her Own Scarf To Shivering Dog Garners Praise On Internet

On August 23, United States Food and Drug ministration gave permission for its use, after US President Donald Trump accused federal ncy of impeding roll-out of vaccines and rapeutics for political reasons.

This technique of curing coronavirus patients involves taking healthy antibody plasma from recovered patients and transferring it to infected patients in hope y would recover. According to international media reports, WHO chief scientist, Soumya Swaminathan said only a few clinical trials produced positive results and re is convincing evidence for this rapy. She also ded a few trials gave some good results, but ir data was inconclusive.

Re: WHO Says 172 Countries Engaging With COVAX Vaccine Plan, Asks For 'crucial Funds'

During a news conference Soumya Swaminathan told "At moment, it's still very low-quality evidence", "So we recommend that convalescent plasma is still an experimental rapy, it should continue to be evaluated in well-designed randomized clinical trials."

Dr. Bruce Aylward, a senior viser to WHO's director-general, said that convalescent plasma rapy can come with numerous side effects, from a mild fever and chills to more severe lung-related injuries

WHO asks for 'crucial funding'

On August 23, World Health Organization said that at least 172 countries are engaging with WHO’s COVAX plan aimed at providing equitable access to COVID-19 vaccine to countries without discrimination. In a live-streamed press conference, WHO said that nations w needed unanimous commitment towards cooperation for crucial new funding needed for COVID-19 vaccine. "Initially, when re will be limited supply (of COVID-19 vaccines), it's important to provide vaccine to those at highest risk around globe," WHO's director-general Tedros ham Ghebreyesus said at a media briefing.

Re: COVID-19: France To Impose 14-day Quarantine On People Travelling From UK

Re: Twitter Attaches Disclaimer On Trump's Tweet, Says It Violates ‘civic, Election Integrity'

(With inputs from ncy)